[1] |
杨志刚, 马希涛, 雷小莉. 多药耐药非发酵菌的临床分布特点及耐药性分析[J]. 中华医院感染学杂志, 2014, 24(1): 25-27. YANG Zhigang, MA Xitao, LEI Xiaoli. Clinical distribution and drug resistance of multidrug-resistant non-fermenting bacteria[J]. Clin J Nosocomiol, 2014, 24(1): 25-27.
|
[2] |
张亮, 周秋云, 陆磊, 等. 雾化吸入阿米卡星在气管支气管结核患者体内的药物分布特点[J]. 临床肺科杂志, 2017, 20(10): 44-47. ZHANG Liang, ZHOU Qiuyun, LU Lei, et al. Distribution characteristics of aerosolized inhaled amikacin in tracheobronchial tuberculosis patients[J]. Clinical Pulmonary Medicine, 2017, 20(10): 44-47.
|
[3] |
Montgomery AB, Vallance S, Abuan T, et al. A randomized double-blind placebo-controlled dose-escalation phase 1 study of aerosolizedamikacin and fosfomycin delivered via the PARI investigational eFlow® inline nebulizer system in mechanically ventilated patients[J]. J Aerosol Med Pulm Drug Deliv, 2014, 27(6):441-448.
|
[4] |
Lu Q, Yang J, Liu Z, et al. Nebulized ceftazidime and amikacin in ventilator-associated pneumonia caused by Pseudomonas aeruginosa[J]. Am J Respir Crit Care Med, 2011, 184(1): 106-115.
|
[5] |
李虎, 杨春辉, 薛杨勇, 等. 雾化吸入抗生素治疗呼吸机相关性肺炎的临床疗效观察[J].中国呼吸与危重监护杂志, 2015, 14(3): 273-277. LI Hu, YANG Chunhui, XUE Yangyong, et al. Efficacy of nebulized antibiotics in treatment of ventilator-associated pneumonia[J]. Clin J Respir Crit Care Med, 2015, 14(3): 273-277.
|
[6] |
Anthony KB, Fishman NO, Linkin DR, et al. Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline[J]. Clin Infect Dis, 2008, 46: 567-570. doi: 10.1086/526775.
|
[7] |
李伟峰, 胡玉洁, 袁伟锋, 等. 气管内滴入与雾化博来霉素致小鼠肺纤维化模型的比较研究[J]. 南方医科大学学报, 2012, 32(2): 221-225. LI Weifeng, HU Yujie, YUAN Weifeng, et al. Comparison of two mouse models of lung fibrosis induced by intratracheal instillation and intratracheal aerosol administration of bleomycin[J]. J South Med Univ, 2012, 32(2): 221-225.
|
[8] |
刘莹, 赖国祥, 周欣, 等. 阿米卡星经纤维支气管镜和静脉给药的药动学比较[J]. 中国医院药学杂志, 2003, 23(2): 97-98. LIU Ying, LAI Guoxiang, ZHOU Xin, et al. The pharmacokinetics of amikacin: comparison of intratracheal administration with intravenous infusion[J]. Chin Hosp Pharm J, 2003, 23(2): 97-98.
|
[9] |
徐叔云. 药理实验方法学[M]. 3版. 北京:人民卫生出版社, 2003: 56.
|
[10] |
Bosken CH, Wiqqs BR, Pare PD, et al. Small airway dimensions in smokers with obstruction to airflow[J]. Am Rev Respir Dis, 1990, 142(3):563-570.
|
[11] |
Mikawa K, Nishina K, Takao Y, et al. ONO-1714, a nitric oxide synthase inhibitor, attenuates endotoxin-induced acute lung in rabbits[J]. Anesth Analg, 2003, 97(6): 1751-1755.
|
[12] |
Sommerwerck U, Virella-Lowell I, Angyalosi G, et al. Long-term safety of tobramycin inhalation powder in patients with cystic fibrosis: phase IV(ETOILES)study[J]. Curr Med Res Opin, 2016, 32(11): 1789-1795.
|
[13] |
Kaku N, Morinaga Y, Takada K, et al. Efficacy and pharmacokinetics of ME1100, a novel optimized formulation of arbekacin for inhalation, compared with amikacin in a murine model of ventilator-associated pneumonia caused by Pseudomonas aeruginosa[J]. J Antimicrob Chemother, 2016, pii: dkw517. doi: 10.1093/jac/dkw517.
|
[14] |
Liu F, Li W, Pauluhn J, et al. Lipopolysaccharide-induced acute lung injury in rats: comparative assessment of intratracheal instillation and aerosol inhalation[J]. Toxicology, 2013, 304: 158-166. doi: 10.1016/j.tox.2012.12.020.
|
[15] |
刘昌英, 晏彬, 谢国秀, 等. 雾化吸入氯化钠颗粒对呼吸道粘膜刺激实验的探讨[J]. 毒理学杂志, 2008, 22(6): 461-463. LIU Changying, YAN Bin, XIE Guoxiu, et al. Experimental study of nasal mucosal irritation induced by aerosolized sodium chloride granules[J]. Journal of Toxicology, 2008, 22(6): 461-463.
|
[16] |
Reed MD, McCombie BE, Sivillo AE, et al. Safety assessment of nebulized xylitol in beagle dogs[J]. Inhal Toxicol, 2012, 24(6): 365-372.
|
[17] |
Hrvacic B, Bosnjak B, Bosnar M, et al. Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma[J]. Eur J Pharmacol, 2009, 616(1-3): 236-243.
|
[18] |
文文, 赖国祥, 姚丽青, 等. 气管内给药对大鼠气管黏膜和肺组织影响的研究[J]. 中国内镜杂志, 2011, 17(10): 1028-1035. WEN Wen, LAI Guoxiang, YAO Liqing, et al. Investigation on injury of tunica mucosa tracheae and lung of rats induced by intratracheal drug administration[J]. Chin J Endosc, 2011, 17(10): 1028-1035.
|
[19] |
Galvao AM, Wanderley MS, Silva RA, et al. Intratracheal co-administration of antioxidants and ceftriaxone reduces pulmonary injury and mortality rate in an experimental model of sepsis[J]. Respirology, 2014, 19(7): 1080-1087.
|
[20] |
Takehara H, Makita M, Tanaka R, et al. Lung toxicity assessment using bronchoalveolar lavage fluid and pleural lavage fluid cytology by intratracheal treatment in rats[J]. J Toxicol Sci, 2014, 39(1): 141-145.
|
[21] |
Kwon JT, Yang YS, Kang MS, et al. Pulmonary toxicity screening of triclosan in rats after intratracheal instillation[J]. J Toxicol Sci, 2013, 38(3): 471-475.
|
[22] |
Haberl N, Hirn S, Wenk A, et al. Cytotoxic and proinflammatory effects of PVP-coated silver nanoparticles after intratracheal instillation in rats[J]. Beilstein J Nanotechnol, 2013, 4: 933-940. doi: 10.3762/bjnano.4.105.
|
[23] |
苑少欣, 孔雅娴, 李蕊, 等. 气管滴注法与雾化吸入法建立小鼠急性肺损伤模型及其效果比较[J]. 中华实验和临床感染病杂志(电子版), 2014, 8(2): 8-12. YUAN Shaoxin, KONG Yaxian, LI Rui, et al. Establishment and effectiveness comparison of mouse models of acute lung injury by intratracheal instillation and aerosol inhalation[J]. Chin J Exp Clin Infect Dis(Electronic Edition), 2014, 8(2): 8-12.
|